Full Text View
Tabular View
No Study Results Posted
Related Studies
Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier
This study is ongoing, but not recruiting participants.
Study NCT00638677   Information provided by University of Turku
First Received: March 12, 2008   Last Updated: November 5, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dental Caries
Infectious Diseases
Additional conditions recognized in this trial
Communicable Diseases
Infection
More general conditions related to this trial
Stomatognathic Diseases
Tooth Demineralization
Tooth Diseases
Interventions listed in this trial
Sorbitol
Xylitol + BB12
Xylitol
More general drug interventions related to this trial
Cathartics
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Turku
Muurame and Korpilahti Health Care Centre, Finland
Chr Hansen, Denmark (provides the BB 12)
Fennobon oy, Karkkila, Finland (provides the tablets for the pacifier)
Plastone Oy, Konnevesi, Finland (provides the pacifiers)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services